Tone mix
Week by week 52 weeks
Share of Dermata Therapeutics, Inc. Common Stock's 138 headlines over the last 52 weeks by the model's call, and the same mix week by week.
Biggest swings in the last year
The weeks whose tone moved furthest from the 8-week average, with the story most outlets carried that week.
- Week of Aug 12, 2024 · tone -100Dermata Therapeutics (NASDAQ:DRMA) Posts Quarterly Earnings Results, Misses Estimates By $0.39 EPS-108
- Week of Dec 2, 2024 · tone +100Dermata Therapeutics: Dermata Completes Enrollment in First Pivotal DMT310 Phase 3 STAR-1 Clinical Trial for Acne+85
- Week of Dec 9, 2024 · tone +100Dermata Therapeutics: Dermata Receives Notice of Allowance for New U.S. Patent for DMT310 for the Treatment of Acne+75
- Week of May 18, 2026 · tone +100Dermata Therapeutics (NASDAQ:DRMA) Issues Earnings Results, Beats Estimates By $0.05 EPS+62
- Week of Jul 22, 2024 · tone +100Why Is Dermata Therapeutics (DRMA) Stock Up 200% Today?+57
- Week of May 12, 2025 · tone 0Dermata Therapeutics Provides Corporate Update and Reports First Quarter 2025 Financial Results-57
Daily headline tone, last 90 sessions
Hover a session for its totals; click to pin.
Each point is the average score of the headlines about Dermata Therapeutics, Inc. Common Stock in one trading session, with the 8-session average drawn through it. Sessions with no headline about the company have no point.
Tone by period
Show the table · 3 rows, 3 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Last 7 sessions | 0 | No headlines |
| Last 30 sessions | 4 | +100 |
| Last 90 sessions | 36 | +30 |
No matching rows. Clear the filter to see all records.
Every headline in the period counts equally.
Headlines on Friday, October 16, 2026
2 headlines, average tone +100: 2 positive, 0 neutral and 0 negative. Showing all 2.
- www.californiatelegraph.com · 2 outletsDermata Therapeutics Announces Positive Topline Results from Cosmetic Study Evaluating Its Tome Foundational TreatmentPositive
- www.investorideas.com · 1 outletSkin in the Game for Dermata Therapeutics, Inc. (NASDAQ:DRMA) Big Gains on Positive Topline Results from Cosmetic StudyPositive
Show the table · 2 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Dermata Therapeutics Announces Positive Topline Results from Cosmetic Study Evaluating Its Tome Foundational Treatment | www.californiatelegraph.com | 2 | Positive |
| Skin in the Game for Dermata Therapeutics, Inc. (NASDAQ:DRMA) Big Gains on Positive Topline Results from Cosmetic Study | www.investorideas.com | 1 | Positive |
No matching rows. Clear the filter to see all records.
Headlines on Thursday, October 15, 2026
2 headlines, average tone +100: 2 positive, 0 neutral and 0 negative. Showing all 2.
- www.pr-inside.com · 1 outletDermata Therapeutics Announces Positive Topline Results from Cosmetic ...Positive
- www.finanznachrichten.de · 1 outletDermata Therapeutics Announces Positive Topline Results from Cosmetic Study Evaluating Its Tome Foundational TreatmentPositive
Show the table · 2 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Dermata Therapeutics Announces Positive Topline Results from Cosmetic ... | www.pr-inside.com | 1 | Positive |
| Dermata Therapeutics Announces Positive Topline Results from Cosmetic Study Evaluating Its Tome Foundational Treatment | www.finanznachrichten.de | 1 | Positive |
No matching rows. Clear the filter to see all records.
Headlines on Tuesday, September 8, 2026
1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.
- www.tickerreport.com · 1 outletCritical Review: Mannatech (NASDAQ:MTEX) versus Dermata Therapeutics (NASDAQ:DRMA)Neutral
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Critical Review: Mannatech (NASDAQ:MTEX) versus Dermata Therapeutics (NASDAQ:DRMA) | www.tickerreport.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Thursday, September 3, 2026
1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.
- www.themarketsdaily.com · 1 outletHead to Head Comparison: Dermata Therapeutics (NASDAQ:DRMA) and Lifevantage (NASDAQ:LFVN)Neutral
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Head to Head Comparison: Dermata Therapeutics (NASDAQ:DRMA) and Lifevantage (NASDAQ:LFVN) | www.themarketsdaily.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Tuesday, September 1, 2026
1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.
- www.themarketsdaily.com · 1 outletAnalyzing Dermata Therapeutics (NASDAQ:DRMA) and Mannatech (NASDAQ:MTEX)Neutral
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Analyzing Dermata Therapeutics (NASDAQ:DRMA) and Mannatech (NASDAQ:MTEX) | www.themarketsdaily.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
How the score works
A headline's tone is not a forecast of the share price. Read the headlines themselves before acting on an average.
Which headlines count
Headlines come from the GDELT global news feed from 2019-09-23 on. A headline counts only when a model judges it to be about Dermata Therapeutics, Inc. Common Stock, not a passing mention.
How each headline is scored
The model calls each headline positive, neutral or negative news for the company. A period's tone is the share of positive minus negative headlines, from -100 (all negative) to +100 (all positive).
When a headline counts
Headlines published by 9:15 a.m. New York time belong to that day's session. Later and weekend headlines move to the next trading session.
Repeated stories
When several outlets carry the same headline, it counts once per session.